Related Experiment Video
Updated: Jan 10, 2026
13:18
Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion
Published on: November 22, 2024
1.9K
Summary
Buprenorphine, a new analgesic, was tested in a large dose suicidal ingestion case. The patient experienced minimal symptoms and made a full recovery, suggesting a potentially favorable safety profile.
Area of Science:
- Pharmacology
- Toxicology
- Clinical Medicine
Background:
- Buprenorphine is a recently approved analgesic undergoing clinical trials.
- Its safety profile, particularly in overdose scenarios, requires further investigation.
Observation:
- This report details a case of intentional large-dose buprenorphine ingestion.
- The patient's clinical presentation and recovery were closely monitored.
Findings:
- Despite the significant dose, the patient exhibited only minimal symptoms.
- Complete recovery was achieved without specific interventions.
Implications:
- These findings suggest a potentially wide safety margin for buprenorphine.
- Further research into buprenorphine's overdose management and toxicity is warranted.
